(Q34896805)

5 August 2017

1 reference

title

Malignant hyperthermia and myotonic disorders (English)

1 reference

5 August 2017

main subject

malignant hyperthermia

1 reference

Harvey K Rosenbaum

1

1 reference

5 August 2017

Jordan D Miller

series ordinal

2

1 reference

5 August 2017

publication date

1 September 2002

1 reference

5 August 2017

published in

Anesthesiology Clinics

1 reference

5 August 2017

volume

20

1 reference

5 August 2017

issue

3

1 reference

5 August 2017

page(s)

623-664

1 reference

Retrospective analysis of anaesthetics received by patients before susceptibility to malignant hyperpyrexia was recognized

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Severe muscular rigidity at birth: malignant hyperthermia syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Malignant hyperthermia: a statistical review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Malignant hyperthermia: a review of published cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Clinical and muscle biopsy findings in malignant hyperthermia susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Halothane-induced porcine malignant hyperthermia: metabolic and hemodynamic changes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Elevated thermostatic setpoint in postoperative patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Does postoperative pyrexia indicate malignant hyperthermia susceptibility?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Prediction of malignant hyperthermia susceptibility: statistical evaluation of clinical signs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Cocaine: clinical pharmacology and toxicology

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Malignant hyperthermia susceptibility in adult patients with masseter muscle rigidity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Upper limb compartment syndromes: a complication of malignant hyperthermia in a patient with ill-defined myopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

A clinical grading scale to predict malignant hyperthermia susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

The sensitivity and specificity of the caffeine-halothane contracture test: a report from the North American Malignant Hyperthermia Registry. The North American Malignant Hyperthermia Registry of MHAUS.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Malignant hyperthermia triggered by heating in anaesthetized pigs.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Evidence for susceptibility to malignant hyperthermia in patients with exercise-induced rhabdomyolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Metabolic error of muscle metabolism after recovery from malignant hyperthermia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Clinical reassessment of malignant hyperthermia in Abitibi-Témiscamingue.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Thyrotoxicosis factitia in the anesthetized patient.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Occurrence of malignant hyperpyrexia in a patient with osteogenesis imperfecta.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Perioperative thermoregulation and heat balance

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Malignant hyperthermia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Cerebral hyperthermia in children after cardiopulmonary bypass.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Neuroleptic malignant syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

The serotonin syndrome. Implicated drugs, pathophysiology and management

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Neurotoxicity of contrast agents

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Salicylate toxicity masquerading as malignant hyperthermia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Influence of thermoregulatory vasomotion and ambient temperature variation on the accuracy of core-temperature estimates by cutaneous liquid-crystal thermometers

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Myoglobinuria after intermittent administration of succinylcholine during halothane anesthesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Hyperkalemic cardiac arrest during anesthesia in infants and children with occult myopathies.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Cardiac arrest after isoflurane anaesthesia in a patient with Duchenne's muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Malignant hyperthermia-like episode in Becker muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Cardiac arrest after succinylcholine: mortality greater with rhabdomyolysis than receptor upregulation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Intramuscular pressures with limb compression. Clarification of the pathogenesis of the drug-induced muscle-compartment syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Acute renal failure due to rhabdomyolysis associated with use of a straitjacket in lysergide intoxication.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Metabolic myopathies. A diagnostic evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Elevated serum cardiac markers in asymptomatic marathon runners after competition: is the myocardium stunned?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Rhabdomyolysis and operating position.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Rhabdomyolysis after abdominal surgery in the hyperlordotic position enforced by pneumatic support.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Massive postoperative rhabdomyolysis after uneventful surgery: a case report of subclinical malignant hyperthermia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Rhadbdomyolysis after coronary artery bypass grafting in a patient receiving simvastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Acute renal failure after cardiopulmonary bypass: a possible association with drugs of the fibrate group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Long-term propofol infusion and cardiac failure in adult head-injured patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Rhabdomyolysis and hypoxia associated with prolonged propofol infusion in children

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Rhabdomyolysis following cardiopulmonary bypass and treatment with enoximone in a patient susceptible to malignant hyperthermia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Myoplasmic free [Ca2+] during a malignant hyperthermia episode in swine.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Caffeine and excitation-contraction coupling in skeletal muscle: a stimulating story

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Malignant hyperthermia and central core disease: disorders of Ca2+ release channels

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Genetics and pathogenesis of malignant hyperthermia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Effects of dantrolene on myoplasmic free [Ca2+] measured in vivo in patients susceptible to malignant hyperthermia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Myoplasmic calcium changes precede metabolic and clinical signs of porcine malignant hyperthermia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Mitochondrial calcium overload: A general mechanism for cell-necrosis in muscle diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Endocrine and metabolic disorders in anaesthesia and intensive care

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Alterations of inositol polyphosphates in skeletal muscle during porcine malignant hyperthermia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

The anesthetic myopathies and malignant hyperthermias.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Lack of prophylactic or therapeutic efficacy of 5-HT2A receptor antagonists in halothane-induced porcine malignant hyperthermia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

How carefully can we phenotype patients suspected of malignant hyperthermia susceptibility?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Intramuscular rocuronium in infants and children: a multicenter study to evaluate tracheal intubating conditions, onset, and duration of action.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. The European Malignant Hyperpyrexia Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Prediction of Malignant Hyperthermia Susceptibility in Low-risk Subjects An Epidemiologic Investigation of Caffeine Halothane Contracture Responses

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

False-negative results with muscle caffeine halothane contracture testing for malignant hyperthermia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Safety of general anesthesia in patients previously tested negative for malignant hyperthermia susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Evaluation of anaesthesias in malignant hyperthermia negative patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Evaluation of 119 anaesthetics received after investigation for susceptibility to malignant hyperthermia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Multicentre evaluation of ryanodine contracture testing in malignant hyperthermia. The European Malignant Hyperthermia Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

A multicenter study of 4-chloro-m-cresol for diagnosing malignant hyperthermia susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

The impact of 4-chloro-m-cresol in heparin formulas on malignant hyperthermia: in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Identification of a Mutation in Porcine Ryanodine Receptor Associated with Malignant Hyperthermia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Identification of novel mutations in the ryanodine-receptor gene (RYR1) in malignant hyperthermia: genotype-phenotype correlation.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

A mutation in the transmembrane/luminal domain of the ryanodine receptor is associated with abnormal Ca2+ release channel function and severe central core disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Halothane Effects on Human Malignant Hyperthermia Skeletal Muscle Single Calcium-release Channels in Planar Lipid Bilayers

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Functional characterization of a distinct ryanodine receptor mutation in human malignant hyperthermia-susceptible muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Caffeine and halothane sensitivity of intracellular Ca2+ release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia and/or central core disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Intracellular calcium homeostasis in human primary muscle cells from malignant hyperthermia-susceptible and normal individuals. Effect Of overexpression of recombinant wild-type and Arg163Cys mutated ryanodine receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

A comparison of the caffeine halothane muscle contracture test with the molecular genetic diagnosis of malignant hyperthermia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Screening of the ryanodine receptor gene in 105 malignant hyperthermia families: novel mutations and concordance with the in vitro contracture test.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Malignant hyperthermia susceptibility, an autosomal dominant disorder?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Multiple interacting gene products may influence susceptibility to malignant hyperthermia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Evidence for the localization of a malignant hyperthermia susceptibility locus (MHS2) to human chromosome 17q

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

A genome wide search for susceptibility loci in three European malignant hyperthermia pedigrees

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Localization of the gene encoding the alpha 2/delta-subunits of the L-type voltage-dependent calcium channel to chromosome 7q and analysis of the segregation of flanking markers in malignant hyperthermia susceptible families.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

The incidence of masseter muscle rigidity after succinylcholine in infants and children

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Jaw relaxation after a halothane/succinylcholine sequence in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Masseter muscle spasm in children: implications of continuing the triggering anesthetic

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Masseter muscle rigidity and malignant hyperthermia susceptibility in pediatric patients. An update on management and diagnosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Isolated masseter muscle spasm and increased creatine kinase without malignant hyperthermia susceptibility or other myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

The effects of succinylcholine on mouth opening.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Masseter muscle rigidity and nondepolarizing neuromuscular blocking agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Antagonism of suxamethonium-induced jaw muscle contracture in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Serum and urinary myoglobin following an aborted malignant hyperthermia reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Strabismus as a possible sign of subclinical muscular dystrophy predisposing to rhabdomyolysis and myoglobinuria: a study of an affected family.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Suxamethonium, masseter spasm and later malignant hyperthermia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Severe rhabdomyolysis in well conditioned athletes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Pathological findings in 165 patients explored for malignant hyperthermia susceptibility.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Malignant hyperthermia and apparent heat stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Is dantrolene effective in heat stroke patients?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Maximal exercise and muscle energy metabolism after recovery from exercise hyperthermia syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Studies of body temperatures, blood lactate, cortisol and free fatty acid levels during exercise in human subjects susceptible to malignant hyperpyrexia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

The death of a British officer-cadet from heat illness

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Successful treatment of an episode of malignant hyperthermia using a large dose of dantrolene

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Preparation of anesthesia machines for patients susceptible to malignant hyperthermia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Are we obsessed with masseter muscle rigidity? Temporomandibular joint disease mistakenly diagnosed as masseter muscle rigidity on two separate occasions in one patient

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

A 10-year study of mortality in a cohort of patients with myotonic dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

The essential mechanism in myotonia; an electromyographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Genetics and physiology of the myotonic muscle disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Myocardial myotonia in myotonic muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Extradural analgesia and dystrophia myotonia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Ventricular tachycardia and sudden death in myotonic dystrophy: clinical, electrophysiologic and pathologic features

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Case history number 90: cardiac decompenstation during enflurane anesthesia in a patient with myotonia atrophica

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Anesthetic and surgical complications in 219 cases of myotonic dystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Anaesthesia and myotonia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Modafinil for excessive daytime sleepiness in myotonic dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Postoperative ventilatory failure in an obese, myopathic woman with periodic somnolence: A case report

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Severe respiratory depression after epidural morphine in a patient with myotonic dystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Propofol in myotonic dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Exaggerated physiological responses to propofol in myotonic dystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Myotonic dystrophy and target-controlled propofol infusions.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Continuous propofol anaesthesia for patients with myotonic dystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Anaesthesia in myotonic dystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Sevoflurane for oesophagoscopy in a patient with myotonic dystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Mivacurium chloride and myotonic dystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Vecuronium for muscle relaxation in patients with dystrophia myotonica.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Hazards of neostigmine in patients with neuromuscular disorders. Report of two cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Anaesthesia in babies with congenital dystrophia myotonica.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Caudal anesthesia for early onset myotonic dystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Myotonic dystrophy and proximal myotonic myophathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Anaesthesia and myotonia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Voltage-gated ion channelopathies: inherited disorders caused by abnormal sodium, chloride, and calcium regulation in skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Malignant hyperthermia in myotonia congenita

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Myotonias and masseter spasm: not malignant hyperthermia?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Malignant hyperthermia and myotonia congenita (Thomsen's disease)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Mutant sodium channels, myotonia, and propofol

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Hypothermic cardiopulmonary bypass in paramyotonia congenita: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

The anesthetic propofol modulates gating in paramyotonia congenita mutant muscle sodium channels

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Masseter muscle rigidity associated with glycine1306-to-alanine mutation in the adult muscle sodium channel alpha-subunit gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Anesthetic complications in muscle disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Hyperkalaemic periodic paralysis and anaesthesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

Natural history of cardiac involvement in myotonic dystrophy: Correlation with CTG repeats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8537%2802%2900011-1

7 January 2021

10.1016/S0889-8537(02)00011-1

Identifiers

DOI

1 reference

5 August 2017

1 reference